News

Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors17/02/2022

The prestigious medical center Georgetown University at Washington DC has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers.

17 Feb|
Read More

PHASE 1B/2A Clinical trial started13/04/2021

The Nerofe Phase 1B/2A trial with high risk MDS and AML patients is taking place at the University of Miami Sylvester Comprehensive Cancer Center.

13 Apr|
Read More

ISK received the FDA’s approval to start Phase 1b/2a with AML patients09/01/2020

09 Jan|
Read More

Cooperation with Harvard Medical School (MGH)27/10/2019

ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases

27 Oct|
Read More